Cabbacis

Cabbacis has secured a new U.S. patent for its novel vaporizer pods, which contain blends of reconstituted tobacco and hemp. This patent, along with existing ones, strengthens the company’s intellectual property in the reduced-harm tobacco product sector. The pods aim to offer distinct taste profiles and utilize hemp as a non-intoxicating component. Cabbacis focuses on harm-reduction innovations, anticipating potential FDA regulations on nicotine content.